Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Overview of attention for article published in JACC: Heart Failure, April 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 X users

bluesky: 5 Bluesky users

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 6 Bluesky posts from 5 Bluesky users, with an upper bound of 10,745 followers.

RP @cardioobdoc.bsky.social: Is #Aficamten Plus #Disopyramide More Effective Than Aficamten Alone in obstructive HCM? #CardioSky #JACCHF www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @jimjanuzzi.bsky.social @robmentz.bsky.social @hvanspall.bsk…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 2 additional Bluesky posts.